Results for tag: "Dihydroergotamine"

Dihydroergotamine (DHE) is a medication used to treat migraine headaches. It is a derivative of ergotamine, a naturally occurring alkaloid found in the ergot fungus. DHE is a vasoconstrictor, meaning it constricts blood vessels, which helps to reduce the pain associated with migraine headaches. It is typically administered as an intramuscular injection, nasal spray, or subcutaneous injection. DHE is a part of the Central Nervous System (CNS) drug market, which includes medications used to treat neurological disorders such as epilepsy, Parkinson's disease, and Alzheimer's disease. CNS drugs are typically used to treat chronic conditions, and as such, the market is expected to remain stable over the long term. Some companies in the DHE market include Novartis, GlaxoSmithKline, Merck, and Pfizer. Show Less Read more